Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atrial fibrillation
MedTech
Boston Scientific claims EU approval for Farapoint PFA catheter
The CE Mark adds the treatment of right atrial flutter to the company’s burgeoning Farapulse platform for irregular heart rhythms.
Conor Hale
Dec 2, 2025 12:28pm
Cardiac tech pushes Medtronic's Q2 earnings past expectations
Nov 18, 2025 11:15am
Medtronic clips EU approval for Penditure LAA implant
Oct 2, 2025 12:00pm
FDA approves Kardium’s Globe pulsed field ablation catheter
Sep 3, 2025 11:00am
Conformal Medical nets $32M to trial foam-based heart occluder
Aug 13, 2025 12:00pm
Boston Scientific expands Farapulse afib reach with new approval
Jul 7, 2025 11:58am
